Back To: Home : Featured Technology : PCR/qPCR

CLICK HERE FOR WHAT'S NEW IN:
 

PerkinElmer forges R&D collaboration with Korea’s Sangmyung University
April 2009
SHARING OPTIONS:

WALTHAM, Mass.—PerkinElmer Inc., a global leader focused on the health and safety of people and the environment, announced last month that it has entered into a drug discovery research collaboration with Sangmyung University in the Republic of Korea. Sangmyung University will apply PerkinElmer's AequoScreen aequorin assay technology to G-protein coupled receptor (GPCR) research campaigns and drug discovery programs in Korea.
 
The partnership is part of the university's efforts to establish an academic GPCR screening facility together with the Korea Chemical Bank, a national repository library of more than 100,000 small molecule compounds. Financial terms of the deal were not disclosed.

"Screening programs have begun to increase in Korea, partly through the support of institutions such as the Center for Biological Modulators (CBM) of the 21st Century Frontier R&D Program (part of the Korean government's Ministry of Science and Technology) for drug discovery research," says Dr. Sunghou Lee, a professor in the university's Department of Biomedical Technology. "For a nationwide academic screening research laboratory such as ours, the ability to reliably and accurately deploy a sensitive, flexible and easy-to-use GPCR detection platform like AequoScreen is of prime importance. This is especially true when dealing with small molecules, where conventional technologies such as fluorescence techniques tend to result in issues such as artifacts and interference that distort results."
 

Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2017 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.